Antibiotics release from cement spacers used for two-stage treatment of implant-associated infections after total joint arthroplasty

J Biomed Mater Res B Appl Biomater. 2019 Jul;107(5):1587-1597. doi: 10.1002/jbm.b.34251. Epub 2018 Oct 12.

Abstract

Two-stage revision arthroplasty is the treatment of choice for periprosthetic infection, a serious complication after knee or hip arthroplasty. Our prospective clinical trial aimed to investigate the concentrations of gentamicin and vancomycin in wound exudate and tissue in two-stage revision arthroplasty. Wound exudate and periprosthetic membrane samples were collected from 18 patients (10 hip and eight knee patients), who were due for two-stage treatment after a periprosthetic joint infection. Samples were taken during insertion of antibiotic-impregnated spacers and after their removal. The concentrations of gentamicin and vancomycin in wound exudates and adjacent tissue were analyzed using high-performance liquid chromatography mass spectrometry. Average time period of spacer implantation was 13.6 weeks (9.3-22.6 weeks). The concentration of vancomycin in wound exudate decreased from a median of 43.28 μg/mL (0.28-261.22) after implantation to 0.46 μg/mL (0.13-37.47) after the removal of the spacer. In the adjacent tissue, vancomycin concentration was mainly undetectable prior to spacer implantation (0.003 μg/g [0.003-0.261]) and increased to 0.318 μg/g [0.024-484.16] at the time of spacer removal. This was also observed for gentamicin in the tissue of patients who previously had cement-free implants (0.008 μg/g [0.008-0.087] vs. 0.164 μg/g [0.048-71.75]) while in the tissue of patients with previously cemented prosthesis, baseline concentration was already high (8.451 μg/g [0.152-42.926]). Despite the rapid decrease in antibiotics release from spacer cement observed in vitro, in vivo antibiotics are much longer detectable, especially in the adjacent soft tissue. © 2018 The Authors. Journal of Biomedical Materials Research Part B: Applied Biomaterials Published By Wiley Periodicals, Inc. J Biomed Mater Res B Part B, 2019. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 1587-1597, 2019.

Keywords: antibiotics release; cement spacer; gentamicin; periprosthetic joint infection; revision arthroplasty; two-stage treatment; vancomycin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology
  • Arthroplasty, Replacement, Hip / methods
  • Arthroplasty, Replacement, Knee / methods
  • Bone Cements / chemistry*
  • Bone Cements / metabolism
  • Drug Carriers / chemistry*
  • Drug Liberation
  • Drug Therapy, Combination
  • Female
  • Gentamicins / chemistry*
  • Gentamicins / metabolism
  • Hip Joint / drug effects
  • Hip Joint / surgery
  • Hip Prosthesis
  • Humans
  • Knee Joint / surgery
  • Male
  • Middle Aged
  • Polymethyl Methacrylate / chemistry*
  • Prospective Studies
  • Prosthesis-Related Infections / drug therapy*
  • Time Factors
  • Vancomycin / chemistry*
  • Vancomycin / metabolism

Substances

  • Anti-Bacterial Agents
  • Bone Cements
  • Drug Carriers
  • Gentamicins
  • Vancomycin
  • Polymethyl Methacrylate